+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Meta-analysis of the incidence and patterns of second neoplasms after photon craniospinal irradiation in children with medulloblastoma



Meta-analysis of the incidence and patterns of second neoplasms after photon craniospinal irradiation in children with medulloblastoma



Pediatric Blood and Cancer 65(8): E27095



Second neoplasms (SNs) are a well-established long-term adverse effect of radiation therapy (RT), but there are limited data regarding their incidence and location relative to the radiation field, specific to medulloblastoma (MB) survivors after craniospinal irradiation (CSI). A systematic literature review, per Preferred Reporting Items for Systematic Reviews and Meta-Analyses, identified six studies reporting the incidence and locations of SNs for 1,114 patients with MB, after CSI, with a median follow-up of ∼9 years (7.6-15.4 years). The study-specific cumulative incidence (CI) of SNs, second benign neoplasms (SBNs), and second malignant neoplasms (SMNs) were standardized to a 10-year time frame. Meta-analysis was performed using random effects models, with pooled data from selected studies and an institutional cohort of 55 patients. The 10-year CI was 6.1% for all SNs (excluding skin cancer and leukemia), 3.1% for SBNs, and 3.7% for SMNs. Fifty-eight percent of SNs were malignant; high-grade glioma was the most common SMN (15/33; 45%) and meningioma, the most common SBN (16/24; 67%). Forty percent of SNs occurred outside the target central nervous system (CNS) field, with a majority in areas of exit RT dose. Seventy-four percent of extra-CNS tumors (17/23) were malignant, most commonly thyroid carcinoma (7/17; 41%) and bone and soft-tissue tumors (6/17, 35%). Survivors of MB are at risk of SNs both within and outside the CNS. A significant proportion of SNs occur in areas of exit RT dose. Studies are needed to determine whether the use of proton therapy, which has no exit RT dose, is associated with a lower incidence of SNs.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 065310771

Download citation: RISBibTeXText

PMID: 29693784

DOI: 10.1002/pbc.27095


Related references

Spinal Growth Patterns After Craniospinal Irradiation in Children With Medulloblastoma. Practical Radiation Oncology 9(1): E22, 2019

Hypothyroidism after craniospinal irradiation with proton or photon therapy in patients with medulloblastoma. Pediatric Hematology and Oncology 35(4): 257-267, 2018

A review of dosimetric and toxicity modeling of proton versus photon craniospinal irradiation for pediatrics medulloblastoma. Acta Oncologica 56(8): 1031-1042, 2017

Comparison of risk of radiogenic second cancer following photon and proton craniospinal irradiation for a pediatric medulloblastoma patient. Physics in Medicine and Biology 58(4): 807-823, 2013

Acute toxicity profile of craniospinal irradiation with intensity-modulated radiation therapy in children with medulloblastoma: A prospective analysis. Radiation Oncology 10: 241, 2015

Multiple neoplasms following craniospinal irradiation for medulloblastoma in a patient with nevoid basal cell carcinoma syndrome. Case report. Journal of Neurosurgery 86(2): 286-288, 1997

A comparative study on the risks of radiogenic second cancers and cardiac mortality in a set of pediatric medulloblastoma patients treated with photon or proton craniospinal irradiation. RadioTherapy and Oncology 113(1): 84-88, 2014

Comparison of supine and prone craniospinal irradiation in children with medulloblastoma. Practical Radiation Oncology 5(2): 93-98, 2015

Predicting intellectual outcome among children treated with 35-40 Gy craniospinal irradiation for medulloblastoma. Neuropsychology 17(4): 548-555, 2003

Patterns of Failure after Craniospinal Irradiation, Intensity Modulated Radiation Therapy (IMRT) Boost and Chemotherapy for Medulloblastoma. International Journal of Radiation Oncology*biology*physics 75(3): S507-S508, 2009

Radiosurgery or hypofractionated stereotactic radiotherapy after craniospinal irradiation in children and adults with medulloblastoma and ependymoma. Child's Nervous System 35(2): 267-275, 2019

A pilot study of preirradiation chemotherapy and 1800 cGy craniospinal irradiation in young children with medulloblastoma. International Journal of Radiation Oncology, Biology, Physics 60(2): 531-536, 2004

Results of a pilot study of very low dose craniospinal irradiation plus chemotherapy for children under five with medulloblastoma An update. International Journal of Radiation Oncology Biology Physics 30(Suppl. 1): 170, 1994

Reducing toxicity from craniospinal irradiation: using proton beams to treat medulloblastoma in young children. Cancer Journal 10(6): 386-390, 2004

Medulloblastoma in very young children: outcome of definitive craniospinal irradiation following incomplete response to chemotherapy. Strahlentherapie und Onkologie 171(4): 247-248, 1995